missing translation for 'onlineSavingsMsg'
Learn More

Mavatrep, MedChemExpress

Product Code. 16433237
Encompass_Preferred
Click to view available options
Quantity:
5 mg
10 mg
50 mg
100 mg
Unit Size:
100mg
10mg
50mg
5mg
This item is not returnable. View return policy

Product Code. 16433237

Brand: Medchem Express HY16935

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MedChemExpress Mavatrep is an orally bioavailable TRPV1 antagonist (Ki=6.5 nM), exhibits minimal effect on the enzymatic activity (IC50 > 25 μM) of CYP isoforms 3A4, 1A2, and 2D6.

Mavatrep is an orally bioavailable TRPV1 antagonist (Ki=6.5 nM), exhibits minimal effect on the enzymatic activity (IC50 > 25 μM) of CYP isoforms 3A4, 1A2, and 2D6.

Specifications

Chemical Name or Material Mavatrep
Physical Form Solid
CAS 956274-94-5
Color Off-White
Quantity 50 mg
Purity Grade Notes Research
Molecular Formula C25H21F3N2O
Synonym JNJ-39439335
Solubility Information DMSO : 16.67 mg/mL (39.46 mM; ultrasonic and warming and heat to 60°C)
SMILES OC(C)(C)C1=CC=CC=C1C2=CC=C3N=C(/C=C/C4=CC=C(C(F)(F)F)C=C4)NC3=C2
Molecular Weight (g/mol) 422.44
Formula Weight 422.44
Percent Purity 98.0%
Grade Research
Show More Show Less

Research purposes only

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.